Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	19,483.80	16,962.50	14,405.20	13,349.10	11,850.40
Sale of Products	19,325.30	16,338.00	13,921.20	13,236.40	11,023.10
Sale of Services	127.70	600.20	428.90	72.00	810.50
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	30.80	24.30	55.10	40.70	16.80
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	19,483.80	16,962.50	14,405.20	13,349.10	11,850.40
Other Income	862.30	591.30	482.00	801.10	743.20
Total Revenue	20,346.10	17,553.80	14,887.20	14,150.20	12,593.60
Changes in Inventories	-238.80	129.50	-389.60	-395.60	-99.90
Cost of Material Consumed	3,291.50	3,161.40	3,378.40	3,266.30	2,556.50
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	1,986.60	1,779.30	2,057.10	1,252.30	1,117.20
Employee Benefits	3,085.70	2,832.60	2,434.60	2,270.10	2,030.20
Total Other Expenses	5,432.40	4,844.90	4,330.60	3,819.20	3,376.80
Manufacturing / Operating Expenses	2,010.40	1,656.00	1,365.70	1,244.30	1,104.90
Administrative and Selling Expenses	3,064.60	2,782.80	2,672.90	2,274.90	2,026.80
Other Expenses	357.40	406.10	292.00	300.00	245.10
Finance Costs	21.80	16.90	38.00	46.70	47.80
Depreciation and Amortization	975.60	923.20	814.30	835.00	789.20
Total Expenses	14,554.80	13,687.80	12,663.40	11,094.00	9,817.80
Profit Before Exceptional Items and Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	5,791.30	3,866.00	2,223.80	3,056.20	2,775.80
Taxation	1,449.30	1,253.20	600.60	869.80	-161.90
Current Tax	1,361.80	864.10	392.60	540.10	483.90
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	87.50	389.10	208.00	329.70	-645.80
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	4,342.00	2,612.80	1,623.20	2,186.40	2,937.70
Earning Per Share - Basic	260.95	157.37	97.85	131.84	177.23
Earning Per Share - Diluted	260.46	157.03	97.58	131.46	176.88

LOGIN HERE

LOGIN HERE

Dr Reddys Laboratories Ltd

Profit and Loss